Transcend Capital Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Transcend Capital Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-23,590	Closed	-$1.25M	–	403
2020 Q3	$1.25M	Buy	23,590 +2,890	+14%	+$178K	0.23%	98
2020 Q2	$1.27M	Hold	20,700	–	–	0.41%	71
2020 Q1	$1.17M	Buy	20,700 +1,000	+5%	+$57K	0.35%	82
2019 Q4	$1.12M	Buy	+19,700	New	+$1.04M	0.3%	96

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Transcend Capital Advisors's BSTC Position: Q4 2020 in Review

Transcend Capital Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 23,590 shares — an estimated $1.25M sold.

Transcend Capital Advisors first reported a position in BSTC in Q4 2019 and held it in 4 quarters. The position peaked at $1.27M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Transcend Capital Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Transcend Capital Advisors sold 23,590 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $1.25M.
Transcend Capital Advisors first reported a position in BioSpecifics Technologies Corp. in Q4 2019 and held it in 4 quarters.
Transcend Capital Advisors's BioSpecifics Technologies Corp. position peaked at $1.27M in Q2 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Transcend Capital Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.